Literature DB >> 9562964

A novel mutation identified in carnitine palmitoyltransferase II deficiency.

B Z Yang1, J H Ding, D Roe, T Dewese, D W Day, C R Roe.   

Abstract

Carnitine palmitoyltransferase II (CPT II) deficiency is an autosomal recessive disorder of mitochondrial fatty-acid oxidation which presents as three distinct phenotypes (neonatal, infantile, and adult onset). CPT II exons from an adult-onset CPT II-deficient patient were amplified and directly sequenced to further investigate the molecular basis of this disorder. A novel mutation, C471T, in exon 4 of the carnitine palmitoyltransferase II gene was found which created a stop codon, TGA, at residue 124 of the protein (R124Stop). This mutation would result in severe protein truncation. This unique mutation was found on one allele while the S113L mutation, previously reported, was present on the other allele.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9562964     DOI: 10.1006/mgme.1997.2656

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  2 in total

1.  Mutation and biochemical analysis in carnitine palmitoyltransferase type II (CPT II) deficiency.

Authors:  S E Olpin; A Afifi; S Clark; N J Manning; J R Bonham; A Dalton; J V Leonard; J M Land; B S Andresen; A A Morris; F Muntoni; D Turnbull; M Pourfarzam; S Rahman; R J Pollitt
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

2.  Carnitine palmitoyltransferase II deficiency: successful anaplerotic diet therapy.

Authors:  C R Roe; B-Z Yang; H Brunengraber; D S Roe; M Wallace; B K Garritson
Journal:  Neurology       Date:  2008-07-22       Impact factor: 9.910

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.